These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 9485196)

  • 21. Primary role of growth-related oncogene-alpha and granulocyte chemotactic protein-2 as neutrophil chemoattractants in chronic rhinosinusitis.
    Rudack C; Sachse F; Alberty J
    Clin Exp Allergy; 2006 Jun; 36(6):748-59. PubMed ID: 16776676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.
    Fan X; Patera AC; Pong-Kennedy A; Deno G; Gonsiorek W; Manfra DJ; Vassileva G; Zeng M; Jackson C; Sullivan L; Sharif-Rodriguez W; Opdenakker G; Van Damme J; Hedrick JA; Lundell D; Lira SA; Hipkin RW
    J Biol Chem; 2007 Apr; 282(16):11658-66. PubMed ID: 17197447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2.
    Wuyts A; Haelens A; Proost P; Lenaerts JP; Conings R; Opdenakker G; Van Damme J
    J Immunol; 1996 Aug; 157(4):1736-43. PubMed ID: 8759763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
    White JR; Lee JM; Young PR; Hertzberg RP; Jurewicz AJ; Chaikin MA; Widdowson K; Foley JJ; Martin LD; Griswold DE; Sarau HM
    J Biol Chem; 1998 Apr; 273(17):10095-8. PubMed ID: 9553055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors.
    Norgauer J; Metzner B; Czech W; Schraufstatter I
    Inflamm Res; 1996 Mar; 45(3):127-31. PubMed ID: 8689391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.
    Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1997 Jun; 272(26):16166-9. PubMed ID: 9195914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase.
    Feniger-Barish R; Yron I; Meshel T; Matityahu E; Ben-Baruch A
    Biochemistry; 2003 Mar; 42(10):2874-86. PubMed ID: 12627953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.
    Gershengorn MC; Geras-Raaka E; Varma A; Clark-Lewis I
    J Clin Invest; 1998 Oct; 102(8):1469-72. PubMed ID: 9788958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor.
    Green SP; Chuntharapai A; Curnutte JT
    J Biol Chem; 1996 Oct; 271(41):25400-5. PubMed ID: 8810307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
    Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
    J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways.
    Schraufstatter IU; Chung J; Burger M
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1094-103. PubMed ID: 11350788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils.
    Luu NT; Rainger GE; Nash GB
    J Immunol; 2000 Jun; 164(11):5961-9. PubMed ID: 10820279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
    Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
    J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage.
    Van Damme J; Wuyts A; Froyen G; Van Coillie E; Struyf S; Billiau A; Proost P; Wang JM; Opdenakker G
    J Leukoc Biol; 1997 Nov; 62(5):563-9. PubMed ID: 9365109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13.
    Jinquan T; Frydenberg J; Mukaida N; Bonde J; Larsen CG; Matsushima K; Thestrup-Pedersen K
    J Immunol; 1995 Dec; 155(11):5359-68. PubMed ID: 7594551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils.
    Petering H; Götze O; Kimmig D; Smolarski R; Kapp A; Elsner J
    Blood; 1999 Jan; 93(2):694-702. PubMed ID: 9885232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.
    Metzner B; Hofmann C; Heinemann C; Zimpfer U; Schraufstätter I; Schöpf E; Norgauer J
    Oncol Rep; 1999; 6(6):1405-10. PubMed ID: 10523720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.